| Smoking as a major risk factor for cervical cancer and pre‐cancer: Results from the EPIC cohort E Roura, X Castellsague, M Pawlita, N Travier, T Waterboer, N Margall, ... International journal of cancer 135 (2), 453-466, 2014 | 405 | 2014 |
| A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries SK Kjaer, M Nygård, J Dillner, J Brooke Marshall, D Radley, M Li, C Munk, ... Clinical Infectious Diseases 66 (3), 339-345, 2018 | 189 | 2018 |
| Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries SK Kjaer, M Nygård, K Sundström, J Dillner, L Tryggvadottir, C Munk, ... EClinicalMedicine 23, 2020 | 157 | 2020 |
| Evaluation of the long-term anti-human papillomavirus 6 (HPV6), 11, 16, and 18 immune responses generated by the quadrivalent HPV vaccine M Nygård, A Saah, C Munk, L Tryggvadottir, E Enerly, M Hortlund, ... Clinical and Vaccine Immunology 22 (8), 943-948, 2015 | 121 | 2015 |
| Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening L Darlin, C Borgfeldt, O Forslund, E Hénic, M Hortlund, J Dillner, ... Journal of Clinical Virology 58 (1), 155-160, 2013 | 106 | 2013 |
| Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort X Castellsague, M Pawlita, E Roura, N Margall, T Waterboer, FX Bosch, ... International journal of cancer 135 (2), 440-452, 2014 | 88 | 2014 |
| Increased serological response against human herpesvirus 6A is associated with risk for multiple sclerosis E Engdahl, R Gustafsson, J Huang, M Biström, I Lima Bomfim, P Stridh, ... Frontiers in Immunology 10, 2715, 2019 | 87 | 2019 |
| Cancer risks after solid organ transplantation and after long‐term dialysis M Hortlund, LS Arroyo Mühr, H Storm, G Engholm, J Dillner, D Bzhalava International journal of cancer 140 (5), 1091-1101, 2017 | 87 | 2017 |
| Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance M Nygård, BT Hansen, J Dillner, C Munk, K Oddsson, L Tryggvadottir, ... PLoS One 9 (2), e88323, 2014 | 51 | 2014 |
| Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs J Dillner, M Nygård, C Munk, M Hortlund, BT Hansen, C Lagheden, ... Vaccine 36 (26), 3820-3829, 2018 | 45 | 2018 |
| Developing a semantically rich ontology for the biobank-administration domain M Brochhausen, MN Fransson, NV Kanaskar, M Eriksson, ... Journal of biomedical semantics 4, 1-9, 2013 | 42 | 2013 |
| Cervical cancer screening in Sweden 2014-2016 M Hortlund, KM Elfström, P Sparén, P Almstedt, B Strander, J Dillner PLoS One 13 (12), e0209003, 2018 | 36 | 2018 |
| Human papillomavirus genotype-specific risks for cervical intraepithelial lesions M Nygård, BT Hansen, SK Kjaer, M Hortlund, L Tryggvadóttir, C Munk, ... Human vaccines & immunotherapeutics 17 (4), 972-981, 2021 | 32 | 2021 |
| Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60 H Lamin, C Eklund, KM Elfström, A Carlsten-Thor, M Hortlund, K Elfgren, ... BMJ open 7 (5), e014788, 2017 | 32 | 2017 |
| Laboratory audit as part of the quality assessment of a primary HPV-screening program M Hortlund, K Sundström, H Lamin, A Hjerpe, J Dillner Journal of Clinical Virology 75, 33-36, 2016 | 26 | 2016 |
| Viruses in cancers among the immunosuppressed LS Arroyo Mühr, Z Bzhalava, M Hortlund, C Lagheden, ... International Journal of Cancer 141 (12), 2498-2504, 2017 | 25 | 2017 |
| Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma H Faust, K Andersson, J Ekström, M Hortlund, TE Robsahm, J Dillner International journal of cancer 134 (4), 844-848, 2014 | 24 | 2014 |
| Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial KM Elfström, C Eklund, H Lamin, D Öhman, M Hortlund, K Elfgren, ... PLoS Medicine 18 (8), e1003748, 2021 | 22 | 2021 |
| Determinants of human papillomavirus vaccine uptake by adult women attending cervical cancer screening in 9 European countries C Robles, L Bruni, A Acera, JC Riera, L Prats, M Poljak, J Mlakar, ... American Journal of Preventive Medicine 60 (4), 478-487, 2021 | 21 | 2021 |
| Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention C Dovey de la Cour, S Guleria, M Nygård, L Trygvadóttir, K Sigurdsson, ... Cancer medicine 8 (2), 839-849, 2019 | 21 | 2019 |
